Back to BlackRock, Inc.CPRX
CPRX6 quarters
Position history for BlackRock, Inc.'s holdings in CATALYST PHARMACEUTICALS INC
BlackRock, Inc. holds 18.8M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $464.9M as of 2026-Q1. The position was increased (+0.8% shares). CPRX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$464.9M
Current Shares
18.8M
Total Value Change
+$59.5M
Total Shares Change
-650,599
Quarter-by-Quarter History
Other major holders of CPRX: BlackRock Finance, Inc., VANGUARD GROUP INC